Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis

Matan Avrahami, Timur Liwinski*, Zafrir Eckstein, Miriam Peskin, Polina Perlman, Jan Sarlon, Undine E. Lang, Daniela Amital, Abraham Weizman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Rationale: : Valproic acid (VPA) is commonly used as a second-line mood stabilizer or augmentative agent in severe mental illnesses. However, population pharmacokinetic studies specific to psychiatric populations are limited, and clinical predictors for the precision application of VPA remain undefined. Objectives: To identify steady-state serum VPA level predictors in pediatric/adolescent and adult psychiatric inpatients. Methods: We analyzed data from 634 patients and 1,068 steady-state therapeutic drug monitoring (TDM) data points recorded from 2015 to 2021. Steady-state VPA levels were obtained after tapering during each hospitalization episode. Electronic patient records were screened for routine clinical parameters and co-medication. Generalized additive mixed models were employed to identify independent predictors. Results: Most TDM episodes involved patients with psychotic disorders, including schizophrenia (29.2%) and schizoaffective disorder (17.3%). Polypharmacy was common, with the most frequent combinations being VPA + quetiapine and VPA + promethazine. Age was significantly associated with VPA levels, with pediatric/adolescent patients (< 18 years) demonstrating higher dose-adjusted serum levels of VPA (β = 7.6±2.34, p < 0.001) after accounting for BMI. Women tended to have higher adjusted VPA serum levels than men (β = 5.08±1.62, p < 0.001). The formulation of VPA (Immediate-release vs. extended-release) showed no association with VPA levels. Co-administration of diazepam exhibited a dose-dependent decrease in VPA levels (F = 15.7, p < 0.001), suggesting a potential pharmacokinetic interaction. Conclusions: This study highlights the utility of population-specific pharmacokinetic data for VPA in psychiatric populations. Age, gender, and co-administration of diazepam were identified as predictors of VPA levels. Further research is warranted to establish additional predictors and optimize the precision application of VPA in psychiatric patients.

Original languageEnglish
JournalPsychopharmacology
DOIs
StateAccepted/In press - 2024

Keywords

  • Co-medication
  • Mood stabilizer
  • Pharmacokinetics
  • Polypharmacy
  • Precision psychiatry
  • Predictors
  • Therapeutic drug-monitoring
  • Valproic acid

Fingerprint

Dive into the research topics of 'Predictors of valproic acid steady-state serum levels in adult and pediatric psychiatric inpatients: a comparative analysis'. Together they form a unique fingerprint.

Cite this